Malignant germ cell tumours in childhood (Q41590230)

4 October 2017

1 reference

title

Malignant germ cell tumours in childhood (English)

1 reference

4 October 2017

Pinkerton CR

1

1 reference

4 October 2017

1 May 1997

1 reference

European Journal of Cancer

4 October 2017

1 reference

4 October 2017

33

1 reference

4 October 2017

6

1 reference

4 October 2017

895-901; discussion 901-2

1 reference

Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide

4 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900157-3

7 January 2021

High complete response rate in children with advanced germ cell tumors using cisplatin-containing combination chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900157-3

7 January 2021

Isochromosome of the short arm of chromosome 12: clinically useful markers for male germ cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900157-3

7 January 2021

Analysis of chromosome 12 aneuploidy in interphase cells from human male germ cell tumors by fluorescence in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900157-3

7 January 2021

Abnormal chromosomes including small metacentrics in 14 ovarian cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900157-3

7 January 2021

Cytogenetics and origins of pediatric germ cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900157-3

7 January 2021

Interphase cytogenetics on paraffin sections of paediatric extragonadal yolk sac tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900157-3

7 January 2021

Cytogenetic analysis of childhood endodermal sinus tumors: a Pediatric Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900157-3

7 January 2021

Cytogenetic and immunohistochemical evidence for the germ cell origin of a subset of acute leukemias associated with mediastinal germ cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900157-3

7 January 2021

Deletion of 1p36 in childhood endodermal sinus tumors by two-color fluorescence in situ hybridization: a pediatric oncology group study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900157-3

7 January 2021

The Second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors. Medical Research Council Testicular Tumour Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900157-3

7 January 2021

Advances in the management of metastatic non-seminomatous germ cell tumours during the cisplatin era: a single-institution experience

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900157-3

7 January 2021

Endodermal sinus tumor of the mediastinum. A report of seven cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900157-3

7 January 2021

The UK Children's Cancer Study Group: Testicular malignant germ cell tumours 1979–1988

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900157-3

7 January 2021

Testicular germ cell tumours of childhood in Denmark, 1943-1989: incidence and evaluation of histology using immunohistochemical techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900157-3

7 January 2021

Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900157-3

7 January 2021

Do all germ cell tumor patients with residual masses in multiple sites require postchemotherapy resections?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900157-3

7 January 2021

Nonseminomatous malignant germ cell tumors in children. Multidrug therapy in stages III and IV

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900157-3

7 January 2021

Lack of late toxicity in patients treated with cisplatin-containing combination chemotherapy for metastatic testicular cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900157-3

7 January 2021

Evaluation of long-term toxicity after chemotherapy for testicular cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900157-3

7 January 2021

Fertility after chemotherapy for testicular germ cell cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900157-3

7 January 2021

Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900157-3

7 January 2021

Primary mediastinal germ cell tumour and acute monocytic leukaemia occurring concurrently in a 15-year-old boy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900157-3

7 January 2021

Hematologic neoplasia associated with primary mediastinal germ-cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900157-3

7 January 2021

Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900157-3

7 January 2021

Cisplatin-etoposide and carboplatin-etoposide induction chemotherapy for good-risk patients with germ cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900157-3

7 January 2021

A randomized trial of cisplatin, etoposide and bleomycin (PEB) versus carboplatin, etoposide and bleomycin (CEB) for patients with 'good-risk' metastatic non-seminomatous germ cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900157-3

7 January 2021

'JEB' – a carboplatin based regimen for malignant germ cell tumours in children

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900157-3

7 January 2021

Effectiveness of carboplatin, etoposide, and bleomycin combination chemotherapy in good-prognosis metastatic testicular nonseminomatous germ cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900157-3

7 January 2021

Carboplatin pharmacokinetics in children: the development of a pediatric dosing formula. The United Kingdom Children's Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900157-3

7 January 2021

The importance of bleomycin in combination chemotherapy for good-prognosis germ cell carcinoma. Australasian Germ Cell Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900157-3

7 January 2021

Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: an Eastern Cooperative Oncology Group trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900157-3

7 January 2021

Sequential trials of cisplatin, vinblastine, and bleomycin and etoposide and cisplatin in disseminated nonseminomatous germ cell tumors of the testis with a good prognosis at a single institution

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900157-3

7 January 2021

A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900157-3

7 January 2021

Two-drug therapy in patients with metastatic germ cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900157-3

7 January 2021

Treatment of endodermal sinus tumor in children using a regimen that lacks bleomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900157-3

7 January 2021

Ifosfamide in refractory male germ cell tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900157-3

7 January 2021

Effective salvage chemotherapy with etoposide, dactinomycin, and methotrexate in refractory germ cell cancer. Australasian Germ Cell Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900157-3

7 January 2021

Salvage chemotherapy in patients with extragonadal nonseminomatous germ cell tumors: the Indiana University experience

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900157-3

7 January 2021

A phase II study of high-dose cisplatin, vinblastine, bleomycin, and etoposide (PVeBV regimen) in malignant nondysgerminomatous germ-cell tumors of the ovary

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900157-3

7 January 2021

High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900157-3

7 January 2021

Feasibility of multiple courses of high-dose cyclophosphamide, thiotepa, and carboplatin for breast cancer or germ cell cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900157-3

7 January 2021

10.1016/S0959-8049(97)00157-3

Identifiers

DOI

1 reference

4 October 2017

1 reference

PubMed ID

9291812